光正眼科股票讨论区

Despite the recent price jump, the company's P/S ratio aligns with the industry, indicating less bearish investor sentiment. However, if the P/S falls to match recent growth rates, investors may face disappointment. The company's poor three-year revenue trends and the industry's higher growth expectations make the current share price seem overvalued unless conditions improve.